March 2023 Publications
- Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant. Duong VT, Skwarczynski M, Toth I. Tuberculosis (Edinb). 2023 Mar. doi: 10.1016/j.tube.2023.102307. Epub 2023 Jan 14.
- BCG vaccination induces enhanced humoral responses in elderly individuals. Kumar NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, Nancy A, Jeyadeepa B, Renji RM, Babu S. Tuberculosis (Edinb). 2023 Mar. doi: 10.1016/j.tube.2023.102320. Epub 2023 Jan 31.
- Peptide-pulsed dendritic cells’ immunomodulating effect regarding Mycobacterium tuberculosis growth in macrophages. Sánchez-Barinas CD, Vergara-Vanegas V, Gamboa-Hernández CM, Ocampo M, Cuello-Oliveros A, Patarroyo MA, Patarroyo ME. Immunobiology. 2023 Mar. doi: 10.1016/j.imbio.2023.152346. Epub 2023 Feb 6.
- Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations. Goudouris E, Aranda CS, Solé D. J Pediatr (Rio J). 2023 Mar-Apr (Suppl 1). doi: 10.1016/j.jped.2022.09.002. Epub 2022 Oct 26.
- The PE-PPE Family of Mycobacterium tuberculosis: Proteins in Disguise. D’Souza C, Kishore U, Tsolaki AG. Immunobiology. 2023 Ma. doi: 10.1016/j.imbio.2022.152321. Epub 2022 Dec 30.
- Advances in development of new tuberculosis vaccines. da Costa C, Onyebujoh P, Thiry G, Zumla A. Curr Opin Pulm Med. 2023 Mar 3. doi: 10.1097/MCP.0000000000000950. Online ahead of print.
- Lentiviral Vectors as a Vaccine Platform against Infectious Diseases. Nemirov K, Bourgine M, Anna F, Wei Y, Charneau P, Majlessi L. Pharmaceutics. 2023 Mar 5. doi: 10.3390/pharmaceutics15030846.
- Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults. Sagawa ZK, Goman C, Frevol A, Blazevic A, Tennant J, Fisher B, Day T, Jackson S, Lemiale F, Toussaint L, Kalisz I, Jiang J, Ondrejcek L, Mohamath J, Vergara J, Lew A, Beckmann AM, Casper C, Hoft DF, Fox CB. Nat Commun. 2023 Mar 6. doi: 10.1038/s41467-023-36789-2.
- Epidemiology of the Koch phenomenon of infants after Bacillus Calmette-Guerin vaccination by interferon-γ release assay status, Japan, 2013-2019. Ota M, Furuichi Y, Hirao S. Int J Mycobacteriol. Jan-Mar 2023. doi: 10.4103/ijmy.ijmy_203_22.
- Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques. Hoft SG, Kauffman KD, Sakai S, Arlehamn CSL, Sette A, Hoft DF, Herbert R, Barber DL. Mbio. 7 March 2023. doi: 10.1128/mbio.00220-23. Online ahead of preprint.
- A Multistage Antigen Complex Epera013 Promotes Efficient and Comprehensive Immune Responses in BALB/c Mice. Qian C, Fan X, Wang R, Cao B, Yu J, Luan X, Li G, Jiang Y, Li M, Zhao X, Fang D, Wan K, Liu H, Lou Y. Vaccines (Basel). 2023 Mar 7. doi: 10.3390/vaccines11030609.
- Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis. Pahuja I, Negi K, Kumari A, Agarwal M, Mukhopadhyay S, Mathew B, Chaturvedi S, Maras JS, Bhaskar A, Dwivedi VP. PLoS Pathog. 2023 Mar 7. doi: 10.1371/journal.ppat.1011165. eCollection 2023 Mar.
- Editorial: Promising roles of functional RNAs in tuberculosis. Pi J, Shen L, Shen H. Front Immunol. 2023 Mar 7. doi: 10.3389/fimmu.2023.1164549. eCollection 2023.
- T cells target TB. Pradhan A, Vorkas CK. Cell Host Microbe. 2023 Mar 8. doi: 10.1016/j.chom.2023.02.003.
- Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells. Morgun E, Zhu J, Almunif S, Bobbala S, Aguilar MS, Wang J, Conner K, Cui Y, Cao L, Seshadri C, Scott EA, Wang C. BioRxiv. 8 March 2023. doi: 10.1101/2023.03.07.531489. Preprint.
- Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience. Saluzzo F, Espinosa-Pereiro J, Dressler S, Tàvora Dos Santos Filho E, Seidel S, Gonzalez Moreno J, Heinrich N, Sanchez-Montalva A, Cirillo DM. Int J Infect Dis. 2023 Mar 9. doi: 10.1016/j.ijid.2023.03.008. Online ahead of print.
- Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG. Mao LR, Du JP, Wang XC, Xu LF, Zhang YP, Sun QS, Shi ZL, Xing YR, Su YX, Wang SJ, Wang J, Ma JL, Zhang JY. ACS Infect Dis. 2023 Mar 10. doi: 10.1021/acsinfecdis.2c00570. Epub 2023 Feb 21.
- Meeting Summary: Global Vaccine and Immunization Research Forum, 2021. Ford A, Hwang A, Mo AX, Baqar S, Touchette N, Deal C, King D, Earle K, Giersing B, Dull P, Hall BF. Vaccine. 2023 Mar 10. doi: 10.1016/j.vaccine.2023.02.028. Epub 2023 Feb 18.
- Neutrophils in Mycobacterium tuberculosis. Alcantara CA, Glassman I, Nguyen KH, Parthasarathy A, Venketaraman V. Vaccines (Basel). 2023 Mar 12. doi: 10.3390/vaccines11030631.
- Safety and Immunogenicity of Recombinant Bacille Calmette-Guérin Strain VPM1002 and Its Derivatives in a Goat Model. Figl J, Köhler H, Wedlich N, Liebler-Tenorio EM, Grode L, Parzmair G, Krishnamoorthy G, Nieuwenhuizen NE, Kaufmann SHE, Menge C. Int J Mol Sci. 14 March 2023. doi: 10.3390/ijms24065509.
- Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation. Witt KD. Front Cell Infect Microbiol. 2023 Mar 15. doi: 10.3389/fcimb.2023.1107884. eCollection 2023.
- The effect of mesenchymal stem cell-derived supernatant nasal administration on lung inflammation and immune response in BCG-vaccinated BALB/c mice. Chenari A, Hazrati A, Hosseini AZ, Motiee M, Soudi S. Life Sci. 2023 Mar 15. doi: 10.1016/j.lfs.2023.121465. Epub 2023 Jan 31.
- Identification and Quantification of S-Sulfenylation Proteome of Mycobacterium tuberculosis under Oxidative Stress. Lu Y, Chen H, Wang P, Pang J, Lu X, Li G, Hu X, Wang X, Yang X, Li C, Lu Y, You X. Microbiol Spectr. 2023 Mar 21. doi: 10.1128/spectrum.03386-22. Online ahead of print.
- Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model. Plumlee CR, Barrett HW, Shao DE, Lien KA, Cross LM, Cohen SB, Edlefsen PT, Urdahl KB. bioRxiv. 22 March 2023. doi: 10.1101/2023.03.22.533820. Preprint.
- TB Vaccines Update: is an RNA-based vaccine feasible for TB? Larsen SE, Baldwin SL, Coler RN. Int J Infect Dis. 22 March 2023. doi: 10.1016/j.ijid.2023.03.035. Online ahead of print.
- Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment. Rangaka MX, Frick M, Churchyard G, García-Basteiro AL, Hatherill M, Hanekom W, Hill PC, Hamada Y, Quaife M, Vekemans J, White RG, Cobelens F. Lancet Respir. 23 March 2023. doi: 10.1016/S2213-2600(23)00084-X.
- Assessing the generation of tissue resident memory T cells by vaccines. Rotrosen E, Kupper TS. Nat Rev Immun. 31 March 2023. doi: 10.1038/s41577-023-00853-1. Online ahead of print.